Delivery Order SPE2DB20D1100-SPE2DB24FZ91A
Award Date 1/25/24
Potential Completion Date 1/26/24
Potential Value $7.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,525.82 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, with a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $2,578.56 by the Defense Logistics Agency (DLA) for the supply of AIMOVIG 70 MG/ML AUTOINJECTOR. The delivery order has a completion date of February 8, 2024. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,520.06 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The delivery order has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,264.14 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide AIMOVIG 140 MG/ML AUTOINJECTORML. The order, which has a completion date of January 11, 2024, is part of Amerisourcebergen's ongoing support of DLA Troop Support Medical programs to supply pharmaceuticals and medical supplies to military treatment facilities. As a prime contractor, Amerisourcebergen has received...
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The $2,528.28 delivery order has a completion date of March 8, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a range of pharmaceuticals and medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order, valued at $5,706.48, is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,140.48 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide AIMOVIG 140 MG/ML autoinjectors. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,264.14 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of AIMOVIG 140 MG/ML AUTOINJECTOR. The $3,160.35 delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,395.48 firm fixed-price delivery order is for AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has an ultimate completion date of July 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...